| 000 | 02874 a2200841 4500 | ||
|---|---|---|---|
| 005 | 20250518042832.0 | ||
| 264 | 0 | _c20200622 | |
| 008 | 202006s 0 0 eng d | ||
| 022 | _a1474-5488 | ||
| 024 | 7 |
_a10.1016/S1470-2045(19)30151-2 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRozeman, Elisa A | |
| 245 | 0 | 0 |
_aIdentification of the optimal combination dosing schedule of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma (OpACIN-neo): a multicentre, phase 2, randomised, controlled trial. _h[electronic resource] |
| 260 |
_bThe Lancet. Oncology _c07 2019 |
||
| 300 |
_a948-960 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntineoplastic Agents, Immunological _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIpilimumab _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMelanoma _xdrug therapy |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoadjuvant Therapy |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 |
_aNivolumab _xadministration & dosage |
| 650 | 0 | 4 |
_aSkin Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aMenzies, Alexander M | |
| 700 | 1 | _avan Akkooi, Alexander C J | |
| 700 | 1 | _aAdhikari, Chandra | |
| 700 | 1 | _aBierman, Carolien | |
| 700 | 1 | _avan de Wiel, Bart A | |
| 700 | 1 | _aScolyer, Richard A | |
| 700 | 1 | _aKrijgsman, Oscar | |
| 700 | 1 | _aSikorska, Karolina | |
| 700 | 1 | _aEriksson, Hanna | |
| 700 | 1 | _aBroeks, Annegien | |
| 700 | 1 | _avan Thienen, Johannes V | |
| 700 | 1 | _aGuminski, Alexander D | |
| 700 | 1 | _aAcosta, Alex Torres | |
| 700 | 1 | _aTer Meulen, Sylvia | |
| 700 | 1 | _aKoenen, Anne Miek | |
| 700 | 1 | _aBosch, Linda J W | |
| 700 | 1 | _aShannon, Kerwin | |
| 700 | 1 | _aPronk, Loes M | |
| 700 | 1 | _aGonzalez, Maria | |
| 700 | 1 | _aCh'ng, Sydney | |
| 700 | 1 | _aGrijpink-Ongering, Lindsay G | |
| 700 | 1 | _aStretch, Jonathan | |
| 700 | 1 | _aHeijmink, Stijn | |
| 700 | 1 | _avan Tinteren, Harm | |
| 700 | 1 | _aHaanen, John B A G | |
| 700 | 1 | _aNieweg, Omgo E | |
| 700 | 1 | _aKlop, Willem M C | |
| 700 | 1 | _aZuur, Charlotte L | |
| 700 | 1 | _aSaw, Robyn P M | |
| 700 | 1 | _avan Houdt, Winan J | |
| 700 | 1 | _aPeeper, Daniel S | |
| 700 | 1 | _aSpillane, Andrew J | |
| 700 | 1 | _aHansson, Johan | |
| 700 | 1 | _aSchumacher, Ton N | |
| 700 | 1 | _aLong, Georgina V | |
| 700 | 1 | _aBlank, Christian U | |
| 773 | 0 |
_tThe Lancet. Oncology _gvol. 20 _gno. 7 _gp. 948-960 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/S1470-2045(19)30151-2 _zAvailable from publisher's website |
| 999 |
_c29760434 _d29760434 |
||